EMD Serono Adds to Leadership Team

EMD Serono, a subsidiary of Merck KGaA, has appointed Allene Diaz, senior vice president, head of U.S. Oncology; Evan Lippman, senior vice president of Neurodegenerative Diseases and Rheumatology; Rami Levin, vice president of marketing, Neurodegenerative Diseases and Rheumatology; and Craig Millian, senior vice president, head of U.S. Fertility, Metabolic Endocrinology and HIV.
 
“It brings me great pleasure to announce the appointments of Craig, Allene and Rami and to welcome Evan to our organization,” said James Hoyes, president of EMD Serono. “Their knowledge, experience and global perspective will strengthen EMD Serono as a leader in biopharmaceuticals in the U.S. Furthermore, these appointments underscore our commitment to recruiting top external talent and promoting great talent from within.”
 
Ms. Diaz will be responsible for leading the commercial efforts for EMD Serono’s U.S. Oncology business. Since 2008, Ms. Diaz has worked to strengthen the company’s oncology presence in the U.S. From July 2010 through April 2011, she also served as acting head, Global Strategic Planning, defining and leading the 2011 strategic planning process for Merck Serono’s Oncology Business Unit.
 
Mr. Lippman joins the company from AstraZeneca, where he most recently served as executive director of the company’s Crestor brand, following a number of leadership roles, including executive director and head of U.S. business development.
 
Mr. Levin joined the company in 1998 and most recently served as chairman and managing director of Merck AB in Sweden and Iceland. Prior to that, he served as global marketing director for Neurology at Merck Serono, Geneva, and as the global product manager for Rebif.
 
Mr. Millian will take over as senior vice president, head of U.S. Fertility, Metabolic Endocrinology and HIV, having held the position on an interim basis earlier this year. Prior to his new role, he served as vice president of Endocrinology Marketing supporting brands across reproductive health, growth hormone deficiency and HIV-related metabolic disorders.
 
Ms. Diaz, Mr. Lippman and Mr. Millian will serve as members of EMD Serono’s executive committee.